Viacheslav Morozov, MD, PhD

LLC Medical Company Hepatolog, Samara, Russian Federation, Russia

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-2191) Efficacy and safety of buleviritide monotherapy for chronic hepatitis D in patients with and without cirrhosis: results from the week 144 interim analysis of a phase 3 randomized study
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT